Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-100211
Filing Date
2024-11-19
Accepted
2024-11-19 17:00:08
Documents
13
Period of Report
2024-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0221641-8ka1_renalytix.htm   iXBRL 8-K/A 43346
  Complete submission text file 0001213900-24-100211.txt   221756

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE renx-20240926.xsd EX-101.SCH 3018
3 XBRL LABEL FILE renx-20240926_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE renx-20240926_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0221641-8ka1_renalytix_htm.xml XML 4379
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39387 | Film No.: 241477048
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)